KR900017584A - Oral antitussive composition - Google Patents

Oral antitussive composition Download PDF

Info

Publication number
KR900017584A
KR900017584A KR1019890006566A KR890006566A KR900017584A KR 900017584 A KR900017584 A KR 900017584A KR 1019890006566 A KR1019890006566 A KR 1019890006566A KR 890006566 A KR890006566 A KR 890006566A KR 900017584 A KR900017584 A KR 900017584A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
animal
human
oral antitussive
tryptophan
Prior art date
Application number
KR1019890006566A
Other languages
Korean (ko)
Inventor
앤 길버트 쉐리
케이 리커 도날드
Original Assignee
원본미기재
리챠드슨-빅스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 리챠드슨-빅스, 인코포레이티드 filed Critical 원본미기재
Publication of KR900017584A publication Critical patent/KR900017584A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

내용 없음No content

Description

경구용 진해 조성물Oral antitussive composition

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (11)

(a)안전하며 유효한 양의 트립토판; 및 (b)안전하며 유효한 양의 경구 진해제를 함유함을 특징으로 하는, 단위 용량 경구 투여에 적합한 해수 치료용 약제학적 조성물.(a) a safe and effective amount of tryptophan; And (b) a safe and effective amount of an oral antitussive agent. 제1항에 있어서, 경구 진해제에 대한 트립토판의 비율이 2:1 내지 5000:1의 범위인 약제학적 조성물.The pharmaceutical composition of claim 1, wherein the ratio of tryptophan to oral antitussive is in the range of 2: 1 to 5000: 1. 제2항에 있어서, 경구 진해제에 대한 트립토판의 비율이 3:1 내지 5000:1의 범위인 약제학적 조성물.The pharmaceutical composition of claim 2, wherein the ratio of tryptophan to oral antitussive is in the range of 3: 1 to 5000: 1. 제3항에 있어서, 경구 진해제에 대한 트립토판의 비율이 8:1 내지 400:1의 범위인 약제학적 조성물.4. The pharmaceutical composition of claim 3, wherein the ratio of tryptophan to oral antitussive is in the range of 8: 1 to 400: 1. 제4항에 있어서, 경구 진해제에 대한 트립토판의 비율이 16:1 내지 100:1의 범위인 약제학적 조성물.The pharmaceutical composition of claim 4, wherein the ratio of tryptophan to oral antitussive is in the range of 16: 1 to 100: 1. 제1항 내지 제5항중 어느 한 항에 있어서, 경구 진해제가 덱스트로메토판, 클로페디아놀, 카르베타펜탄, 카르아미펜, 노스카핀, 디펜하이드라민, 코데인, 하이드로코돈, 하이드로모르폰, 포미노벤, 이의 약제학적으로 허용되는 염, 및 이의 혼합물로 이루어진 그룹중에서 선택되는 약제학적 조성물.6. The oral antitussive according to claim 1, wherein the oral antitussive agent is dextrometopan, clopedanol, carbetapentane, caramifen, noscapine, diphenhydramine, codeine, hydrocodone, hydromorphone, po A pharmaceutical composition selected from the group consisting of minobene, pharmaceutically acceptable salts thereof, and mixtures thereof. 제6항에 있어서, 시럽, 유제, 현탁제 또는 액제의 형태인 약제학적 조성물.7. A pharmaceutical composition according to claim 6 in the form of a syrup, emulsion, suspension or liquid. 제6항에 있어서, 정제 로젠지 캅셀제 과립제 또는 빌트산제의 형태인 약제학적 조성물.The pharmaceutical composition according to claim 6, which is in the form of tablet lozenge capsule granules or bilates. 해수의 치료를 필요로하는 사람 또는 동물에게 제1항 내지 제6항중 어느 한 항에 따른 약제학적 조성물을 투여함을 특징으로 하여, 사람 또는 동물의 해수를 치료하는 방법.A method of treating seawater in a human or animal, characterized by administering the pharmaceutical composition according to any one of claims 1 to 6 to a human or animal in need of treatment of the seawater. 해수의 치료를 필요로하는 사람 또는 동물에게 제7 항에 따른 약제학적 조성물을 투여함을 특징으로 하여, 사람 또는 동물의 해수를 치료하는 방법.A method of treating seawater in a human or animal, characterized by administering the pharmaceutical composition according to claim 7 to a human or animal in need of treatment of seawater. 해수의 치료를 필요로 하는 사람 또는 동물에게 제8항에 따른 약제학적 조성물을 투여함을 특징으로 하여, 사람 또는 동물의 해수를 치료하는 방법.A method of treating seawater in a human or animal, characterized by administering the pharmaceutical composition according to claim 8 to a human or animal in need of treatment of seawater. ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890006566A 1988-05-18 1989-05-17 Oral antitussive composition KR900017584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19557888A 1988-05-18 1988-05-18
US195,578 1988-05-18

Publications (1)

Publication Number Publication Date
KR900017584A true KR900017584A (en) 1990-12-19

Family

ID=22721947

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890006566A KR900017584A (en) 1988-05-18 1989-05-17 Oral antitussive composition

Country Status (5)

Country Link
JP (1) JPH0262823A (en)
KR (1) KR900017584A (en)
AU (1) AU3489789A (en)
NZ (1) NZ229164A (en)
PH (1) PH26900A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100610252B1 (en) * 2004-07-01 2006-08-10 주식회사 엘지생활건강 Iontophoresis device

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395115A (en) * 1989-06-15 1991-04-19 Taisho Pharmaceut Co Ltd Antitussive

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100610252B1 (en) * 2004-07-01 2006-08-10 주식회사 엘지생활건강 Iontophoresis device

Also Published As

Publication number Publication date
JPH0262823A (en) 1990-03-02
AU3489789A (en) 1989-11-23
NZ229164A (en) 1992-02-25
PH26900A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
KR920702216A (en) Use of Acetyl D-Carnitine in Glaucoma Treatment
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
KR890009376A (en) Spray dried ibuprofen
ES2035821T3 (en) INTEGRATED DIRECTED ADMINISTRATION SYSTEM.
KR890000101A (en) How to improve the treatment of banwol tissue and therapeutic drugs
KR850700109A (en) Antidiuretic DDAVP and its preparation method
DK0724885T3 (en) Pernasal composition and pernasal preparation containing this
KR880002515A (en) Fast absorbing and acting sullindac or a mixture of sodium sullindak and base
KR910019618A (en) Pharmaceutical composition for treating erectile dysfunction
KR950703972A (en) TRANSADERMAL ADMINISTRATION SYSTEM CONTAINING ACETYLSALICYLIIC ACID FOR ANTITHROMBOTIC THERAPY AND THE PREVENTION OF CANCER
NO177376C (en) Process for the preparation of a pharmaceutical dosage form based on a tampon printing method
KR900005978A (en) Antimalarial Compositions and Methods of Treatment Using Kininidine, Artemisinin and Derivatives thereof
KR950013513A (en) Moenomycin and its derivatives for the manufacture of a medicament, and a medicament containing moenomycin or its derivatives
KR900017584A (en) Oral antitussive composition
KR970701047A (en) ANTITUSSIVE COMPOSITION CONTAINING AN ANTITUS SIVE AND BENZYDAMINE
KR920702225A (en) Pharmaceutical composition
JPS5781409A (en) External plaster
KR890003373A (en) Use of compounds to treat sleep disorders and depression
KR870010082A (en) Guar powder
KR890007728A (en) Painkiller
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
KR900017583A (en) Oral antitussive composition
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination